Transforming Growth Factor Alpha (TGF-α)

More Novel Tests

References

Artagaveytia, N. L. (1997). Epidermal growth factor and transforming growth factor alpha mRNA expression in human breast cancer biopsies; analysis in relation to estradiol, progesterone and EGF receptor content. The Journal of Steroid Biochemistry and Molecular Biology, 30(3-4), 221-228.Auvinen, P. K. (1996). Prognostic significance of TGF-alpha expression in breast cancer. Acta Oncologica, 35(8), 995-998.Balcan, E. D. (2012). Serum levels of epidermal growth factor, transforming growth factor, and c-erb2 in ovarian cancer. International Journal of Gynecological Cancer, 2(7), 1138-1142.Chakrabarty, S. H. (1994). Elevated serum levels of transforming growth factor-alpha in breast cancer patients. Cancer Letters, 79(2), 157-160.Chien, C. H. (1997). Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay. Gynecologic Oncology, 66(3), 405-410.Choi, J. H. (1999). Detection of transforming growth factor-alpha in the serum of gastric carcinoma patients. Oncology, 57(3), 236-241.Coffey, R. J. (1992). Roles for transforming growth factor-alpha in gastric physiology and pathophysiology. The Yale Journal of Biology and Medicine, 65(6), 693-704.Derynck, R. (1992). The physiology of transforming growth factor-alpha. Advances in Cancer Research, 58, 27-52.El-Sherif, W. T. (2012). Evaluation of transforming growth factor alpha and vascular endothelial growth factor in diagnosis of hepatocellular carcinoma. The Egyptian Journal of Immunology, 19(2), 53-65.El-Tayeh, S. F. (2012). Serological biomarkers of hepatocellular carcinoma in Egyptian patients. Disease Markers, 32(4), 255-263.Hao, C. L. (2018). Expression and clinical significance of EGF and TGF alpha in chronic pancreatitis and pancreatic cancer. Minerva Endocrinologica, 43(3), 253-258.Harper, M. E. (1993). An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors. The Prostate, 23(1), 9-23.Hsuan, J. J. (2004). Transforming Growth Factor (TGF) Alpha. In Encyclopedia of Endocrine Diseases (1 ed., Vol. 4, pp. 605-611). Elsevier Inc.Jeng, J. E. (2014). Urinary transforming growth factor α and serum α-fetoprotein as tumour markers of hepatocellular carcinoma. Tumour Biology, 35(4), 3689-3698.Keeley, B. R. (2014). Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and oesophageal cancer. Cancer Science, 105(9), 1205-1211.Kjær, I. M. (2020). Dysregulated EGFR pathway in serum in early-stage breast cancer patients: a case control study. Scientific Reports, 10(1).Konturek, P. C. (1997). Mucosal expression and luminal release of epidermal and transforming growth factor in patients with duodenal ulcer before and after eradication of Helicobacter pylori. Gut, 40(4), 463-469.Konturek, P. C. (1998). Epidermal growth factor and transforming growth factor alpha in duodenal ulcer and non-ulcer dyspepsia patients before and after Helicobacter pylori eradication. Scandinavian Journal of Gastroenterology, 32(2), 143-151.Konturek, P. C. (2001). Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Ba and Bcl-2, and gastrin in human gastric cancer. Alimentary Pharmacology & Therapeutics, 15(7), 989-999.Korc, M. C. (1992). Overexpression of the epidermal growth receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. The Journal of Clinical Investigation, 90(4), 1352-1360.Kozłowski, M. B. (2023). Preoperative serum levels of PDGF-AB, PDGF-BB, TGF-alpha, EGF and ANG-2 in the diagnosis of endometrial cancer. Cancers, 15(19).Lee, D. C. (2003). CHAPTER 41 - EGF Family Ligands. In A. W. Thomson (Ed.), The Cytokine Handbook (pp. 959-987). Academic Press.Moskal, T. L. (1995). Serum levels of transforming growth factor alpha in gastrointestinal cancer patients. Cancer Epidemiology, Biomarkers & Prevention, 4(2), 127-131.Myers, R. B. (1993). Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptos in adenocarcinoma of the prostate and benign prostate hyperplasia. Modern Pathology, 6(6), 733-737.Shim, K. S. (1998). Increased serum levels of transforming growth factor-alpha in patients with colorectal cancer. Diseases of the Colon and Rectum, 41(2), 219-24.Stachura, J. K. (1996). Growth markers in the human gastric mucosa during adaptation to continued aspirin administration. Journal of Clinical Gastroenterology, 22(4), 282-287.Tomiya, T. (1993). Serum levels of transforming growth factor-alpha in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. Hepatology, 18(2), 304-308.Tomiya, T. (1996). Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis. Cancer, 77(6), 1056-1060.Yamamoto, T. H. (1988). Interaction between transforming growth factor-alpha and c-Ha-ras p21 in progression of human gastric carcinoma. Pathology, Research and Practice, 183(6), 663-669.Yeh, Y. C. (1987). Elevation of transfroming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Research, 47(3), 896-901.Yoshida, K. K. (1990). Expression of epidermal growth factor, transforming growth factor-alpha and their receptor genes in human gastric carcinomas; implication for autocrine growth. Japanese Journal of Cancer Research, 81(1), 43-51.Zahra, M. K. (1999). Serum transforming growth factor alpha in liver cirrhosis and hepatocellular carcinoma. Pediatric Research, 45(5), 775-775.